STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALT
  4. [ARS] Altimmune, Inc. SEC Filing

[ARS] Altimmune, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Altimmune, Inc.

ARS Filing - Altimmune, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Altimmune, Inc. (ALT)

Acceptance Date: 2026-03-17T07:13:05.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Altimmune

NASDAQ:ALT

View ALT Stock Overview →

ALT Rankings

#3618 Ranked by Market Cap
N/A Ranked by Dividends

ALT Latest News

Mar 5, 2026
Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates
Mar 2, 2026
Altimmune to Participate in Upcoming Investor Conferences
Feb 26, 2026
Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026
Jan 29, 2026
Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock
Jan 27, 2026
Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock

ALT Latest SEC Filings

Mar 17, 2026
[DEF 14A] Altimmune, Inc. Definitive Proxy Statement
Mar 9, 2026
[Form 4] Altimmune, Inc. Insider Trading Activity
Mar 9, 2026
[Form 4] Altimmune, Inc. Insider Trading Activity
Mar 6, 2026
[PRE 14A] Altimmune, Inc. Preliminary Proxy Statement
Mar 6, 2026
[10-K] Altimmune, Inc. Files Annual Report

ALT Stock Data

421.54M
129.21M
Biotechnology
Pharmaceutical Preparations
Link
United States
GAITHERSBURG